← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Cefotaxime currently has availability issues reported in 4 European registers: Germany, Spain, Ireland, Sweden.
Shortage ATC J01DD01 · also listed as: Cefotaxim-Natrium · CEFOTAXIMA · Cefotaxime · cefotaximnatrium · data refreshed 13 September 2026
As of 13 September 2026, 4 of the 9 tracked registers list current availability issues for Cefotaxime, covering 6 affected product presentations. The longest-running open report was filed in Sweden on 2023-04-04 and has now been open for about 41 months. Where agencies state a cause, manufacturing problems lead with 3 of the 3 stated-cause reports. The furthest expected-resolution date currently on file is 2030-11-21; the earliest is 2026-11-13. Momentum is current, not historical: 3 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Sweden reported first (2023-04-04), with Germany following roughly 41 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Spain, Ireland, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Cefotaxime is coded J01DD01 — a medicine acting on anti-infectives for systemic use — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage Cefotaxim-saar 1 g Pulver zur Herstellung einer Injektions- bzw. Infusionslösung + 1 more productsCefotaxim-saar 2 g Pulver zur Herstellung einer Injektions- bzw. Infusionslösung | 2026-09-01 | 2026-11-30 | Herstellerwechsel Alternatives: N/A | register ↗ |
| 🇪🇸 Spain | Shortage CEFOTAXIMA SALA 1G POLVO PARA SOLUCION INYECTABLE EFG, 100 viales + 1 more productsCEFOTAXIMA SALA 2 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSIÓN EFG, 50 viales | 2026-04-06 | 2030-11-21 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇮🇪 Ireland | Shortage Cefotaxime 1g Powder for solution for injection or infusion | 2024-05-15 | — | Manufacturing delay Alternatives: Alternative(s) available — see the national register. | register ↗ |
| 🇸🇪 Sweden | Shortage Cefotaxim MIP 2 g Pulver till injektions-/infusionsvätska, lösning | 2023-04-04 | 2027-04-30 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Cefotaxime in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇩🇪 DE | Cefotaxim-saar 1 g Pulver zur Herstellung einer Injektions- bzw. Infus | Shortage | 2026-09-01 | 2026-11-30 | Herstellerwechsel |
| 🇩🇪 DE | Cefotaxim-saar 2 g Pulver zur Herstellung einer Injektions- bzw. Infus | Shortage | 2026-09-01 | 2026-11-30 | Herstellerwechsel |
| 🇪🇸 ES | CEFOTAXIMA SALA 2 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSIÓN EF | Shortage | 2026-07-23 | 2030-11-21 | Existen otros medicamentos con el mismo principio activo y m |
| 🇪🇸 ES | CEFOTAXIMA SALA 1G POLVO PARA SOLUCION INYECTABLE EFG, 100 viales | Shortage | 2026-04-06 | 2026-11-13 | Existen otros medicamentos con el mismo principio activo y m |
| 🇮🇪 IE | Cefotaxime 1g Powder for solution for injection or infusion | Shortage | 2024-05-15 | — | Manufacturing delay |
| 🇸🇪 SE | Cefotaxim MIP 2 g Pulver till injektions-/infusionsvätska, lösning | Shortage | 2023-04-04 | 2027-04-30 |
Yes. As of 13 September 2026, availability issues are reported in: Germany, Spain, Ireland, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-11-13 to 2030-11-21. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
6 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Cefotaxime: BfArM (Germany), AEMPS CIMA (Spain), HPRA (Ireland), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Cefotaxime — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/cefotaxime/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Cefotaxime availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/cefotaxime/">Cefotaxime shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>